Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis

BACKGROUND: Long-term usage of glucocorticoids results in a loss of bone mass and a higher risk of fracture, and the most common cause of secondary osteoporosis is glucocorticoid-induced osteoporosis (GIOP). For preventing GIOP, bisphosphonate (BP) is widely used. However, analysis on BP’s effect on...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Hongmin, Jang, Bo-Hyoung, Kim, GaYoon, Bae, Seowoo, Lee, Hyeju, Nam, Seonghee, Ahn, Jeonghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Medical Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516213/
https://www.ncbi.nlm.nih.gov/pubmed/36167395
http://dx.doi.org/10.1136/bmjopen-2022-062537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516213/
https://www.ncbi.nlm.nih.gov/pubmed/36167395
http://dx.doi.org/10.1136/bmjopen-2022-062537

Ejemplares similares